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Objectives. We investigated whether ultrasmall paramagnetic particles of iron oxide- (USPIO-) enhanced magnetic resonance
imaging (MRI) can detect experimental chronic allograft damage in a murine renal allograft model. Materials and Methods. Two
cohorts of mice underwent renal transplantation with either a syngeneic isograft or allograft kidney. MRI scanning was performed
prior to and 48 hours after USPIO infusion using 𝑇2∗-weighted protocols. 𝑅2∗ values were calculated to indicate the degree of
USPIO uptake. Native kidneys and skeletal muscle were imaged as reference tissues and renal explants analysed by histology and
electron microscopy. Results. 𝑅2∗ values in the allograft group were higher compared to the isograft group when indexed to native
kidney (median 1.24 (interquartile range: 1.12 to 1.36) versus 0.96 (0.92 to 1.04), 𝑃 < 0.01). 𝑅2∗ values were also higher in the
allograft transplant when indexed to skeletal muscle (6.24 (5.63 to 13.51)) compared to native kidney (2.91 (1.11 to 6.46) 𝑃 < 0.05).
Increased 𝑅2∗ signal in kidney allograft was associated with macrophage and iron staining on histology. USPIO were identified
within tissue resident macrophages on electron microscopy. Conclusion. USPIO-enhanced MRI identifies macrophage.
1. Introduction
Chronic allograft damage (CAD), characterised by interstitial
fibrosis and tubular atrophy (IFTA), is the commonest cause
of transplant failure following surgery [1]. The demand for
organ transplantation is expanding and waiting lists for a
kidney are likely to increase in coming years [2]. Early iden-
tification of chronic allograft damage remains challenging
but is crucial to allow intervention with immunosuppressive
therapy. Renal biopsy remains the gold-standard for detecting
allograft rejection but is associated with significant morbidity
and mortality. The average complication rate is 7.4% with a
life-threatening complication occurring in 1% [3, 4]. It would
be advantageous to have a noninvasive imaging approach
for the detection of acute rejection and IFTA. This would
provide an alternative or adjunctive clinical assessment that
may reduce the number of biopsies.
Current imaging techniques for monitoring allograft
function involve the use of ultrasound to exclude ureteric
obstruction or vascular compromise in the failing kidney.
Measurement of vascular resistive index or the use of
contrast-enhanced ultrasonography has been advocated but
has not been clinically validated [5–7]. There is no imaging
modality available to measure the development of graft fibro-
sis and current practice involves a biopsywhen renal function
deteriorates [8]. The role of monocytes and macrophages in
chronic renal allograft damage has been well established [9].
Monocytes and macrophages are known to play a role in
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chronic renal allograft damage [10] and are key promoters
of fibrosis in other organs, such as the liver [11, 12]. Several
animal models of allograft rejection exhibit monocyte and
macrophage infiltration in allograft tissue [13–17], and these
cells have a central role in human chronic allograft damage
[18, 19]. We have developed a model of chronic allograft
damage: characterised by a single class II mismatch a kidney
from C57BL/6BM12 (H-2BBM12) donor is transplanted into a
C57BL/6 (H-2B) recipient and leads to the progressive devel-
opment of interstitial fibrosis and tubular atrophy (IFTA)
over 4 to 8 weeks. The key role of macrophages in this model
has been demonstrated when transplants were performed
into galectin-3 knockout recipients on aC57Bl/6 background.
This led to an alteration in macrophage phenotype with
reduced numbers of YM1-expressing macrophages in the
knockout group and protection from IFTA [10].
Magnetic resonance imaging (MRI) offers detailed char-
acterization of the kidney structure without using ioniz-
ing radiation and is suitable for monitoring renal allograft
damage with repeated scanning. Iron oxide particles have
been used as a contrast medium for MRI as they alter the
𝑇2
∗ relaxation time of tissues in which they accumulate
[20]. Ultrasmall (approximately 30 nm), superparamagnetic
particles of iron oxide (USPIO) extravasate freely through
capillaries and are taken up by tissue-resident inflammatory
cells of the reticuloendothelial system [21]. Available USPIO
include ferumoxytol (Rienso, Takeda; Feraheme, AMAG
Pharmaceuticals), which is licensed for the treatment of
anaemia caused by iron deficiency in patients with chronic
kidney disease rather than as a contrast agent for MRI.
Together with other groups, we have used USPIO as MRI
contrast in clinical studies [20, 22–24].
Monocytes, macrophages, and to a lesser extent neu-
trophils take up USPIO, and accumulation in allograft
rejection can be identified [25, 26]. MRI detected USPIO
accumulation within the outer renal medulla in a model
of renal ischaemia and this correlated histologically with
USPIO uptake by macrophages [27]. USPIO have been used
to investigate acute renal transplant rejection in preclini-
cal models; however, these effects may have been due to
ischaemia reperfusion injury [28, 29]. We hypothesized that
they could be used to identify inflammation and fibrosis in a
model of chronic renal allograft damage.
2. Materials and Methods
2.1. Murine Model of Renal Transplantation. Two cohorts of
C57BL/6 mice underwent renal transplantation. Syngeneic
renal transplants (𝑛 = 8) were performed between littermates
and allograft renal transplants from C57BL/6BM12 donors
into C57Bl/6 recipients (𝑛 = 10). Characterised by a sin-
gle class II mHC mismatch, such kidneys develop chronic
allograft damage over a progressive twelve-week period.
The model is not transplant-dependent as the contralateral
kidney is left in situ. The isograft transplanted kidney and
the native nontransplanted kidney were available as controls
for comparison with the allograft kidney. Mice were bred
in-house in the Biomedical Research Resources, University
of Edinburgh, or purchased from Charles River. All animal
experiments were performed under a project licence and
in accordance with legislation in the Home Office Animal
(Scientific Procedures) Act of 1986. Baseline MRI scanning
was performed 4weeks after transplant followed immediately
by an infusion of USPIO by tail vein injection (4mg/kg
ferumoxytol; Rienso, Takeda). Repeat MRI scanning was
performed 48 hours after infusion.
2.2. MR Imaging Protocols. All MRI experiments were per-
formed using a 7-Tesla horizontal bore NMR spectrometer
(Agilent Technologies, Yarnton, UK), equipped with a high-
performance gradient insert (60-mm inner diameter), maxi-
mum gradient strength 1000mT/m. Mice were anaesthetised
with 1.5% isoflurane in oxygen/air (50/50, 1 L/min) and
placed in a cradle (Rapid Biomedical GmbH, Rimpar, Ger-
many).The rectal temperature and respiration rateweremon-
itored throughout the experiments, and body temperature
was maintained at 37∘C with a heat fan. A 33-mm diameter
birdcage volume coil (Rapid Biomedical GmbH, Rimpar,
Germany) was used for radio frequency transmission and
signal reception. For anatomical assessment and to aid place-
ment of the slice for the 𝑇2∗ mapping sequence, respiration-
gated 𝑇2-weighted fast spin echo images (echo train length
of 8) of 1-mm slice thickness in a coronal orientation were
collected with the following parameters: repetition time (TR)
≈ 3000ms depending on the respiration rate; effective echo
time = 36ms; 16 slices, field of view = 35mm × 35mm;
matrix = 192 × 128, 2 signal averages. For 𝑇2∗ mapping and
calculation of 𝑇2∗ relaxation times, image acquisition used
a gradient-echo, respiratory-gated pulse sequence (dummy
pulses during respiratorymovement) of 7 images weighted in
𝑇2
∗ acquired consecutively: TE = 1.83, 3, 5, 7, 10, 12, and 15ms
and a TR of 60ms. The field of view was 35 × 35mm and the
acquisition matrix 192 × 128 (in-plane resolution = 0.182 ×
0.273mm). Slice thickness was 1-mm with 2 signal averages.
USPIO imaging was performed with 𝑇2∗-weighted
gradient-echo sequences using a 7 T MRI scanner. Quantita-
tive analysis of USPIO accumulation was achieved by calcu-
lation of𝑇2∗ relaxation times before and after administration
of USPIO [20]. In order to optimise image analysis and
prevent degradation due to “𝑇2∗-blooming” artefacts, images
were quantitatively analysed using a susceptibility gradient
mapping postprocessing technique previously used in SPIO
imaging to quantitate USPIO accumulation using changes in
calculated 𝑇2∗ relaxation times [30].
2.3. Image Analysis. The seven echoes in the multiecho
𝑇2
∗-weighted sequence were combined to generate a 𝑇2∗
map, in which the data represented the 𝑇2∗ value (𝑆(𝑡) =
𝑆(0) exp(−𝑡/𝑇2∗)) for each voxel.This was achieved using in-
house software developed in Matlab (Mathworks, USA). The
𝑇2
∗ value is the decay constant for the exponential decay
of signal intensity with time. In the presence of USPIO, the
signal decays more rapidly due to local field inhomogeneities
and the 𝑇2∗ value is reduced. By minimising the sum of
the squares of errors between the data and an exponential
function, the decay constant (i.e., 𝑇2∗ in ms) was obtained.
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An experimentally determined threshold for the coefficient
of determination (𝑟2 > 0.85) was used to exclude data that
did not have an acceptable exponential decay when SI was
plotted against echo time. The inverse of 𝑇2∗, 𝑅2∗, was
then calculated to assess USPIO uptake. The greater the
accumulation of USPIO in tissues, the greater the 𝑅2∗ value.
𝑅2
∗ values were obtained from baseline and 48-
hour scans using ANALYZE software (AnalyzeDirect
Software, United States). Regions of interest were drawn
on parenchyma, and pre-USPIO scans compared to post-
USPIO scans. A semiquantitative analysis was made from the
increase in𝑅2∗ value. To correct for differences in blood pool
USPIO concentration, due to infusion errors or difference
in blood volume, the transplanted kidney 𝑅2∗ increase was
indexed to the native kidney 𝑅2∗ increase. To provide a value
of translational value to clinical medicine, where a normal
healthy native kidney will not be present, the renal 𝑅2∗
increase was also indexed to skeletal muscle 𝑅2∗ increase.
2.4. Allograft Injury: Histology. Kidneys were divided and
fixed fresh frozen or in methyl Carnoy’s solution and
embedded in paraffin. Tissue sections were stained with
haematoxylin-eosin to allow histological analysis and reveal
presence of inflammatory infiltrate [31, 32].
2.5. Allograft Injury: Cellular Infiltrate. Macrophage infil-
tration was identified by F4/80+ (Abcam, Cambridge, UK)
staining by immunohistochemistry using paraffin embedded
tissue sections. Light microscopy was performed and images
were obtained and quantified by computer-assisted image
analysis of 10 sequentially selected nonoverlapping fields of
renal cortex and medulla and expressed as the percentage of
tissue surface area positive for staining.
2.6. Electron Microscopy. For transmission electron micro-
scopy, samples were fixed in 3% glutaraldehyde in 0.1M
sodium cacodylate buffer, pH 7.3, for 2 h and then postfixed in
1% osmium tetroxide in 0.1M sodium cacodylate for 45min.
Samples were then dehydrated and embedded in araldite
resin. Ultrathin 60-nm sections were cut from selected areas,
stained in uranyl acetate and lead citrate and then viewed in
a Philips CM120 transmission electron microscope, images
obtained with a Gatan Orius CCD camera.
2.7. Statistical Analysis. Statistical analysis was performed
with GraphPad Prism version 4.00 (GraphPad Software,
San Diego, California, USA). Grafts were compared with
native kidneys using paired two-tailed nonparametric 𝑡-
tests (Wilcoxon matched-pairs signed rank test). Isograft
and allograft kidneys were compared using nonpaired two-
tailed nonparametric 𝑡-tests (Mann-Whitney test). Statistical
significance was taken as a two-sided 𝑃 < 0.05.
3. Results
One allograft and 2 isograft recipients sustained infarction
of the transplanted kidney. This left 9 allograft mice and 6
isograft mice for analysis.
3.1. Change in 𝑅2∗ Values in Allograft and Isograft Kidneys.
IllustrativeMRI scans with𝑅2∗ signal derived colourmaps of
USPIO uptake in allograft and isograft kidneys are shown in
Figures 1(a) and 1(b). Increased𝑅2∗ signal andUSPIO uptake
are indicated by green and red colour.
Baseline 𝑅2∗ values were similar in native (median
(interquartile range), 42.8 (38.5 to 50.5)ms−1) and allograft
kidneys (44.2 (39.6 to 52.8)ms−1). USPIO administration
increased 𝑅2∗ values in both isograft and allograft kidneys
(Figure 1). The increase in 𝑅2∗ value at 48 h was greater
in allograft kidneys (30.15 (14.0 to 68.0)ms−1) compared
to native kidney (15.7 (4.5 to 26.8)ms−1), 𝑃 < 0.01. In
contrast, the increased 𝑅2∗ signal in isograft kidneys at 48 h
(23.24ms−1 (7.53 to 71.2)ms−1) was not different to native
kidney (26.4ms−1 (3.71 to 86.9)ms−1), 𝑃 = 0.58.
𝑅2
∗ value increases indexed for changes in native kidney
and skeletal muscle are shown in Figure 2. Median increase
(interquartile range), indexed for native kidney, was greater
in allografts 1.24 (1.12 to 1.36) compared to isografts 0.96
(0.92 to 1.04), 𝑃 < 0.01, Figure 2(a). A similar result was
obtained following indexing for skeletal muscle 𝑅2∗ increase
(Figure 2(b)). The median increase in 𝑅2∗ value indexed to
skeletal muscle was greater in the allograft kidney 6.24 (5.63
to 13.51) compared to native kidney 2.91 (1.11 to 6.46), 𝑃 <
0.05.The corresponding skeletal muscle indexed signals were
similar in isograft 3.83 (0.78 to 6.24) and native kidneys 3.63
(1.00 to 5.33) and significantly lower than the allograft signal,
𝑃 < 0.05.
3.2. Histology and Electron Microscopy. F4/80 staining con-
firmed heavy macrophage resident cells in the allograft kid-
neys (2.70±0.84 percentage area staining) with very few cells
in the isograft kidneys (0.52 ± 0.44 percentage area staining)
(Figures 3(a) and 3(b)). Iron staining with Prussian blue
demonstrated deposition in allograft tissue with none in the
isograft tissue.The reticuloendothelial tissue of the spleenwas
also rich inmonocyte and iron staining. Electronmicroscopy
confirmed monocyte/macrophage USPIO uptake within the
renal tissue (Figure 3(c)).
4. Discussion
We have shown for the first time that USPIO-enhanced MRI
can detect macrophage infiltration in a model of chronic
inflammatory allograft damage. The prospect of noninvasive
detection and monitoring of CAD, without resorting to renal
biopsy, would be a significant advance in the management of
renal transplant patients.
In this study the allograft USPIO signal was significantly
increased compared to the native kidney. This direct com-
parison would be not feasible in a clinical study where the
native kidney would be diseased or absent. Additionally
human pathological factorsmay impact on theUSPIO related
signal. USPIO has a circulating half-life of 18–30 hours and
persistence of particles in the circulation will affect the tissue
𝑅2
∗ value due to perfusion [33]. In this study, differences
in blood volume and organ perfusion, due to surgical blood
loss or physiological variation related to inflammation and
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(a)
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Figure 1: (a) Transplanted kidney (white arrows) compared to native kidney (yellow arrows) for allograft. (b) Transplanted kidney (white
arrows) compared to native kidney (yellow arrows) for isograft.
rejection, may contribute to the blood pool related signal in
each animal. To address this problem, we indexed USPIO
signal to skeletal muscle and native kidney.These findings on
noninvasive imaging were associated with greatly increased
macrophage infiltration andUSPIO iron staining in allografts
compared to isografts. We were able to further demonstrate
macrophage USPIO uptake on scanning electronmicroscopy
confirming that the USPIO signal on MRI was related to the
macrophage infiltration in CAD.
It was not possible to be certain about the mechanism
of cell labeling and distribution of USPIO within renal
tissue. As a result of their smaller size, USPIO are less
readily recognized by phagocytic cells and persist in the
circulation for longer than other iron particles (plasma half-
life 14–30 h in humans) [33, 34]. They are capable of passing
through capillary walls, to be taken up through pinocytosis
by tissue-resident macrophages and neutrophils [21, 25, 26].
ExtravasatedUSPIOmay remain in the interstitial space or be
taken up by resident macrophages. Circulating USPIO may
also be taken up by monocytes that subsequently infiltrate
the kidney.These processes (monocyte uptake, USPIO blood
extravasation, and resident macrophage uptake) may have
different kinetics and could all contribute to the increased
USPIO signal in allografts. The study aim was to provide
proof of principle that allograft rejection can be detected
noninvasively with contrast MRI but this approach could be
used to further dissect out CAD mechanisms.
Significant advances have been made in the management
of acute rejection as modern immunosuppressive agents tar-
get primarily T lymphocytes. However, the rate of CAD char-
acterized by interstitial fibrosis remains relatively constant,
giving rise to the loss of 4% renal transplants per year. Work
from our own group has demonstrated that modification
of macrophage biology can protect against fibrosis in this
model of CAD and the role of macrophages in renal and liver
fibrosis has been well established [10–12, 35]. Examination of
macrophage phenotype was beyond the remit of this study,
which focused primarily on imaging, but would be of interest
to determine whether the macrophages were predominantly
YM1-expressing profibrotic phenotype.
One limitation of the study is that imagingwas performed
at 4 weeks after transplant, when there was already histolog-
ical evidence of fibrosis and, as the model is not transplant-
dependent, it is not possible to ascertain whether deteriora-
tion in renal function had already occurred. However this is a
proof of principle investigation to determine the feasibility of
International Journal of Molecular Imaging 5
2.0
1.5
1.0
0.5
0.0
P = 0.0016
Median with interquartile range
Allograft
cohort cohort
Isograft
Tr
an
sp
la
nt
 R
2
∗
/n
at
iv
e R
2
∗
(a)
Allograft
cohort cohort
Isograft
30
20
10
0
−10
P = 0.0117
P = 0.0256
Median with interquartile range
N
at
iv
e
Tr
an
sp
la
nt
ed
N
at
iv
e
Tr
an
sp
la
nt
ed
Re
na
lR
2
∗
in
cr
ea
se
/m
us
cle
R
2
∗
in
cr
ea
se
(b)
Figure 2: Increase in 𝑅2∗ value from baseline to 48 hours for transplanted kidney indexed to native kidney (a) and skeletal muscle (b).
such an approach, and subsequent work will require imaging
at earlier time points and correlating with renal function.
Blooming artefact associated with 𝑇2∗/𝑅2∗ imaging with
MRI is another potential limitation. These distortions can
be erroneously included in the region of interest covering
the renal tissue leading to falsely high 𝑅2∗ readings. In our
study, this was particularly evident when the spleen laden
with USPIO could distort the values in the neighbouring
transplanted kidney. Care was taken to avoid drawing regions
of interest over such areas. In addition, 𝑇2∗/𝑅2∗ imaging
identifies areas or tissue edema or hemorrhage in other
organs, and as such the differing 𝑅2∗ values of baseline scans
may have been due to differing amounts of edema [36].
Finally, the relationship between 𝑅2∗ value and iron accu-
mulation is nonlinear, and so absolute increase in 𝑅2∗ value
may not be directly proportional to increased inflammation
[37]. The technique is semiquantitative and so increasing
values do indicate an increase in the number of monocytes or
macrophages in a tissue or an increase in activity.There was a
range of values in the allograft group, suggesting a differing
amount of inflammation in the different allografts. As the
mechanism of rejection in this model of CAD is multifaceted
a single measurement at 4 weeks is expected to have variation
given that this model develops gradual histological injury up
to 12 weeks and beyond [38].
The USPIO agent, ferumoxytol, is used as an intravenous
iron supplementation agent for patients with end-stage renal
failure. It has a good safety profile and is an ideal agent for
investigation of transplant rejection in patients [39]. Further
translational studies are needed to identify if there is a 𝑅2∗
threshold value which would identify a level of excessive
inflammation requiring alteration of therapy.
In conclusion, we have developed an MRI technique
for detecting inflammation in a model of chronic renal
allograft damage. The protocol employs USPIO contrast that
is compatible with patients who have renal dysfunction. This
noninvasive approach for the detection of changes of CAD
offers the possibility of avoiding renal biopsy in somepatients.
Translational studies are required to assess its applicability in
clinical practice.
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Figure 3: (a) F4/80 staining (top panel) for monocyte derived macrophages in the spleen and allograft and isograft (hollow arrows). Prussian
blue staining (bottom panel) comparing iron deposition in the spleen, allograft tissue, and isograft (sold black arrows). (b) Histological
monocyte count in allograft, isograft, and nontransplanted native kidneys. (c) Electron microscopy of macrophages in renal allograft tissue.
The inlay (top right, magnification from black box) demonstrates USPIO within lysosomes.
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